Analysis of Structure–Activity Relationships of Food-Derived DPP IV-Inhibitory Di- and Tripeptides Using Interpretable Descriptors
Source abstract
Abstract
This study aimed to analyze the structural requirements for di- and tripeptides exhibiting a DPP IV-inhibitory effect. The sequences of 46 di- and 33 tripeptides, including their bioactivity (IC50; μM), were implemented from the BIOPEP-UWM database, whereas modeling was performed using SCIGRESS Explorer: Version FJ 3.5.1 software. Models included 336 (dipeptide dataset) and 184 descriptors (tripeptide dataset). The values of the determination coefficient (R2) defining model reliability were 0.782 and 0.829 for di- and tripeptides, respectively. Based on the implemented descriptors, it was concluded that increased numbers of nitrogen atoms, as well as the methyl groups, are required for dipeptides to enhance the DPP IV-inhibitory effect. This was indicated by the presence of amino acids with an aliphatic side chain (e.g., Leu, Val, Ile) and an aromatic ring (Trp). In the case of tripeptides, a correlation was found between their molecular weight (MW) and studied bioactivity. A tripeptide with a molecular weight of up to 500 Da was found suitable for the sequence to act as the DPP IV inhibitor. Although there is still a gap in explaining the relations between the structural nature and the DPP IV-inhibitory activity of peptides, and certain issues related to this topic still remain unknown, the results are in line with those reported by other authors. Additionally, the suitability of the SCIGRESS tool in the QSAR analysis of peptides derived from foods can be confirmed. Interpretable descriptors enabled the achievement of more unequivocal results concerning the main structural factors affecting the DPP IV inhibition of di- and tripeptides.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Protein Hydrolysis and Bioactive Peptides · Peptidase Inhibition and Analysis · Neuropeptides and Animal Physiology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chair of Food Biochemistry, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Pl. Cieszyński 1, 10-726 Olsztyn-Kortowo, Poland
FQS Poland (Fujitsu Group), Parkowa 11, 30-438 Kraków, Poland
Funding
Minister of Education and Science
References (47)
Show source-provided references
1. Production and processing of antioxidant bioactive peptides: A driving force for the functional food market10.1016/j.heliyon.2020.e04765 ↗
2. Rapeseed protein-derived ACE inhibitory peptides LY, RALP and GHS show antioxidant and anti-inflammatory effects on spontaneously hypertensive rats10.1016/j.jff.2019.02.031 ↗
3. Techniques, perspectives, and challenges of bioactive peptide generation: A comprehensive systematic review10.1111/1541-4337.12578 ↗
4. Dhar, H., Verma, S., Dogra, S., Katoch, S., Vij, R., Singh, G., and Sharma, M. (2023). Functional attributes of bioactive peptides of bovine milk origin and application of in silico approaches for peptide prediction and functional annotations. Crit. Rev. Food Sci. Nutr.10.1080/10408398.2023.2212803 ↗
5. Potential anti-inflammatory and lipase inhibitory peptides generated by in vitro gastrointestinal hydrolysis of heat treated millet grains10.1080/19476337.2019.1580317 ↗
6. Liu, R., Cheng, J., and Wu, H. (2019). Discovery of food-derived dipeptidyl peptidase IV inhibitory peptides: A review. Int. J. Mol. Sci., 20.10.3390/ijms20030463 ↗
7. Zhang, M., Zhu, L., Wu, G., Liu, T., Qi, X., and Zhang, H. (2023). Food-derived dipeptidyl peptidase IV inhibitory peptides: Production, identification, structure-activity relationship, and their potential role in glycemic regulation. Crit. Rev. Food Sci. Nutr.10.1080/10408398.2022.2120454 ↗
8. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes10.1017/S0029665113003601 ↗
9. Bioinformatics approaches to discovering food-derived bioactive peptides: Reviews and perspectives10.1016/j.trac.2023.117051 ↗
10. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di- and tripeptides10.1021/jf051263l ↗
11. Chemometric analysis of the amino acid requirements of antioxidant food protein hydrolysates10.3390/ijms12053148 ↗
12. Modelling relationship between angiotensin-(I)-converting enzyme inhibition and the bitter taste of peptides10.1016/j.foodchem.2006.06.026 ↗
13. Hrynkiewicz, M., Iwaniak, A., Bucholska, J., Minkiewicz, P., and Darewicz, M. (2019). Structure-activity prediction of ACE inhibitory/bitter dipeptides-a chemometric approach based on stepwise regression. Molecules, 24.10.3390/molecules24050950 ↗
14. (2023, October 20). Available online: https://scopus.com.
15. Molecular modeling of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile as a Dipeptidyl Peptidase IV (DPP4) Inhibitor10.7324/JAPS.2018.81001 ↗
16. Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D &3D QSAR, in vivo radiolabeling and bio distribution studies10.1016/j.bioorg.2018.09.021 ↗
17. Riyaphan, J., Pham, D.C., Leong, M.K., and Weng, C.F. (2021). In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes. Biomolecules, 11.10.3390/biom11121877 ↗
18. Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates10.1016/j.foodchem.2017.10.033 ↗
19. Learnings from quantitative structure activity relationship (QSAR) studies with respect to food protein-derived bioactive peptides: A review
20. Structure-activity relationships study on biological activity of peptides as dipeptidyl peptidase IV inhibitors by chemometric modeling10.1111/cbdd.13643 ↗
21. iDPPIV-SCM: A sequence-based predictor for identifying and analyzing dipeptidyl peptidase IV (DPP-IV) inhibitory peptides using a scoring card method10.1021/acs.jproteome.0c00590 ↗
22. StackDPPIV: A novel computational approach for accurate prediction of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides10.1016/j.ymeth.2021.12.001 ↗
23. Minkiewicz, P., Iwaniak, A., and Darewicz, M. (2019). BIOPEP-UWM database of bioactive peptides: Current opportunities. Int. J. Mol. Sci., 20.10.3390/ijms20235978 ↗
24. Replacement method and enhanced replacement method versus the genetic algorithm approach for the selection of molecular descriptors in QSPR/QSAR theories10.1021/ci100103r ↗
25. Strengths and limitations of in silico tools to assess physicochemical properties, bioactivity, and bioavailability of food-derived peptides10.1016/j.tifs.2023.06.023 ↗
26. Benigni, R. (2003). Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens, CRC Press.10.1201/9780203010822 ↗
27. A machine learning workflow for molecular analysis: Application to melting points10.1088/2632-2153/ab8aa3 ↗
28. (2023, October 20). Scikit-Learn Integration Package for Apache Spark. Available online: https://github.com/databricks/spark-sklearn.
29. Best Practices for QSAR Model Development, Validation, and Exploitation10.1002/minf.201000061 ↗
30. Jenkins, D.G., and Quintana-Ascencio, P.F. (2020). A solution to minimum sample size for regressions. PLoS ONE, 15.10.1371/journal.pone.0229345 ↗
31. Best Practices for QSAR Model Reporting: Physical and Chemical Properties, Ecotoxicity, Environmental Fate, Human Health, and Toxicokinetics Endpoints10.1289/EHP3264 ↗
32. Reference sample size for multiple regression in corn10.1590/s1678-3921.pab2020.v55.01400 ↗
33. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity10.1007/s00894-011-1265-3 ↗
34. Basic Validation Procedures for Regression Models in QSAR and QSPR Studies: Theory and Application10.1590/S0103-50532009000400021 ↗
35. On Over-fitting in Model Selection and Subsequent Selection Bias in Performance Evaluation
36. Statistical modeling of soil moisture, integrating satellite remote-sensing (SAR) and ground-based data10.3390/rs70302752 ↗
37. Paneth, A., Płonka, W., and Paneth, P. (2019). Assessment of nonnucleoside inhibitors binding to HIV-1 reverse transcriptase using HYDE scoring. Pharmaceuticals, 12.10.3390/ph12020064 ↗
38. Classification of organic molecules by Molecular Quantum Numbers10.1002/cmdc.200900317 ↗
39. Andrescu, T., Mushkarov, O., and Stoyanov, L. (2006). Geometric Problems in Maxima and Minima, Birkhäuser. Available online: https://www.isinj.com/mt-usamo/Geometric%20Problems%20on%20Maxima%20and%20Minima%20-%20Titu%20Andreescu,%20Oleg%20Mushkarov,%20Luchezar%20Stoyanov.pdf.
40. Guasch, L., Ojeda, M.J., González-Abuín, N., Sala, E., Cereto-Massagué, A., Mulero, M., Valls, C., and Pinent, M. (2012). Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): Virtual screening and activity assays. PLoS ONE, 7.10.1371/journal.pone.0044971 ↗
41. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings10.1016/S0169-409X(00)00129-0 ↗
42. Oral administration of peptide-based drugs: Beyond Lipinski’s Rule10.1002/cmdc.201600288 ↗
43. PubChem and ChEMBL beyond Lipinski10.1002/minf.201900016 ↗
44. Nongonierma, A.B., and FitzGerald, R.J. (2019). Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins. J. Food Biochem., 43.10.1111/jfbc.12451 ↗
45. The (re)-evolution of Quantitative Structure–Activity Relationship (QSAR) studies propelled by the surge of machine learning methods10.1021/acs.jcim.2c01422 ↗
46. QSAR studies of angiotensin converting enzyme inhibitors using CoMFA, CoMSIA and molecular docking: Scientific paper10.2298/JSC200615072T ↗
47. Iwaniak, A., Hrynkiewicz, M., Bucholska, J., Minkiewicz, P., and Darewicz, M. (2019). Understanding the nature of bitter-taste di- and tripeptides derived from food proteins based on chemometric analysis. J. Food Biochem., 43.10.1111/jfbc.12500 ↗